Patent intelligence · US
US 12350245
Stable oral suspensions of baclofen
Stable oral suspensions of baclofen
Patent details — US 12350245
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 8, 2025
- Expiration
- Jul 3, 2045
- Applicant
- ANI Pharmaceuticals, Inc.
- Claims
- 19
- CPC classes
- A61K, A61K31/197, A61K47/36, A61K47/38
Quick answer
US 12350245 (Stable oral suspensions of baclofen) is held by ANI Pharmaceuticals, Inc.. Status: granted. Granted Jul 8, 2025. Expires Jul 3, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ANI Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 19
- CPC classes
- A61K, A61K31/197, A61K47/36, A61K47/38, A61K9/0053, A61K9/0095
More from ANI Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12324787
Kits for preparing and delivering purified corticotropin
granted -
US 12233105
Methods for storing and warming purified corticotropin compositions
granted -
US 12133831
Kits for preparing and delivering purified corticotropin
granted -
US 12102662
Methods for storing and warming purified corticotropin compositions
granted -
US 11975047
Methods for storing and warming purified corticotropin compositions
granted -
US 11857524
Stable oral suspensions of baclofen
granted
Frequently asked questions
What is US patent 12350245?
US 12350245 (Stable oral suspensions of baclofen) is held by ANI Pharmaceuticals, Inc.. Status: granted. Granted Jul 8, 2025. Expires Jul 3, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12350245?
ANI Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.
When does US 12350245 expire?
Our index shows an expiration date of Jul 3, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.